Searle ends collaboration with Hybridon

G. D. Searle (Skokie, Ill.) will not extend its 1996 R&D collaboration with HYBN to develop antisense compounds of MDM2. MDM2 is a protein involved in apoptosis. Up until January 2000, Searle was maki...